356 related articles for article (PubMed ID: 28418093)
1. Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2.
Hulley PA; Bishop T; Vernet A; Schneider JE; Edwards JR; Athanasou NA; Knowles HJ
J Pathol; 2017 Jul; 242(3):322-333. PubMed ID: 28418093
[TBL] [Abstract][Full Text] [Related]
2. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
[TBL] [Abstract][Full Text] [Related]
3. Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells.
Rauner M; Franke K; Murray M; Singh RP; Hiram-Bab S; Platzbecker U; Gassmann M; Socolovsky M; Neumann D; Gabet Y; Chavakis T; Hofbauer LC; Wielockx B
J Bone Miner Res; 2016 Oct; 31(10):1877-1887. PubMed ID: 27082941
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α regulates osteoclast activation and mediates osteogenesis during mandibular bone repair via CT-1.
Tian Y; Shao Q; Tang Y; Li X; Qi X; Jiang R; Liang Y; Kang F
Oral Dis; 2022 Mar; 28(2):428-441. PubMed ID: 33274496
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for the hypoxia-inducible transcription factors HIF-1α and HIF-2α in human osteoclast formation and function.
Knowles HJ
Sci Rep; 2020 Dec; 10(1):21072. PubMed ID: 33273561
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α regulates osteoclastogenesis and alveolar bone resorption in periodontitis via ANGPTL4.
Qi X; Bie M; Jiang R; Kang F
Arch Oral Biol; 2023 Sep; 153():105736. PubMed ID: 37290266
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.
Knowles HJ; Cleton-Jansen AM; Korsching E; Athanasou NA
FASEB J; 2010 Dec; 24(12):4648-59. PubMed ID: 20667978
[TBL] [Abstract][Full Text] [Related]
8. ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment.
Zhu K; Jiao H; Li S; Cao H; Galson DL; Zhao Z; Zhao X; Lai Y; Fan J; Im HJ; Chen D; Xiao G
J Bone Miner Res; 2013 Sep; 28(9):1870-1884. PubMed ID: 23649506
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast-Osteoclast Coculture Amplifies Inhibitory Effects of FG-4592 on Human Osteoclastogenesis and Reduces Bone Resorption.
Hulley PA; Papadimitriou-Olivgeri I; Knowles HJ
JBMR Plus; 2020 Jul; 4(7):e10370. PubMed ID: 32666021
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Induced Fibroblast Growth Factor 11 Stimulates Osteoclast-Mediated Resorption of Bone.
Knowles HJ
Calcif Tissue Int; 2017 Apr; 100(4):382-391. PubMed ID: 28097375
[TBL] [Abstract][Full Text] [Related]
14. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
[TBL] [Abstract][Full Text] [Related]
15. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL
Breast Cancer Res; 2011 Feb; 13(1):R16. PubMed ID: 21291529
[TBL] [Abstract][Full Text] [Related]
16. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
17. Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Regulates Chondrocyte Differentiation and Secondary Ossification in Mice.
Cheng S; Aghajanian P; Pourteymoor S; Alarcon C; Mohan S
Sci Rep; 2016 Oct; 6():35748. PubMed ID: 27775044
[TBL] [Abstract][Full Text] [Related]
18. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Hsieh TP; Sheu SY; Sun JS; Chen MH
Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
